iRhythm Technologies (IRTC)

• Market cap: $2.83B
• 1 day: 3.11%
• 5 days: 4.53%
• 1 month: 22.58%
• 3 months: 29.13%
• 6 months: -14.22%
• Year to date: -10.81%
• 1 year: -14.31%
• 5 years: 48.18%
• 10 years: 246.99%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Employees: 2,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

87% more call options, than puts

Call options by funds: $64.1M | Put options by funds: $34.3M

36% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 36

28% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 67

6% more funds holding

Funds holding: 225 [Q2] → 238 (+13) [Q3]

5.55% less ownership

Funds ownership: 115.3% [Q2] → 109.76% (-5.55%) [Q3]

34% less capital invested

Capital invested by funds: $3.86B [Q2] → $2.55B (-$1.32B) [Q3]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $78 14% downside
• Avg. target: $100 11% upside
• High target: $152 68% upside

6 analyst ratings

• positive: 4 67%
• neutral: 2 33%
• negative: 0 0%

Truist Securities Richard Newitter 80% 1-year accuracy 40 / 50 met price target	23% upside $111	Buy Maintained	18 Dec 2024
Canaccord Genuity William Plovanic 57% 1-year accuracy 26 / 46 met price target	68% upside $152	Buy Maintained	9 Dec 2024
Wells Fargo Nathan Treybeck 60% 1-year accuracy 3 / 5 met price target	5% downside $86	Equal-Weight Reinstated	3 Dec 2024
Baird Mike Polark 100% 1-year accuracy 2 / 2 met price target	13% downside $79	Outperform Maintained	1 Nov 2024
Needham David Saxon 25% 1-year accuracy 15 / 61 met price target	6% upside $96	Buy Maintained	31 Oct 2024